Assessing the antifungal activity of a new oral lipid-based amphotericin B formulation following administration to rats infected with Aspergillus fumigatus.
about
Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™.Rodent Models of Invasive Aspergillosis due to Aspergillus fumigatus: Still a Long Path toward Standardization.Design of amphotericin B oral formulation for antifungal therapy.Review and analysis of FDA approved drugs using lipid-based formulations.The oral delivery of amphotericin B
P2860
Assessing the antifungal activity of a new oral lipid-based amphotericin B formulation following administration to rats infected with Aspergillus fumigatus.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Assessing the antifungal activ ...... ed with Aspergillus fumigatus.
@en
Assessing the antifungal activ ...... ed with Aspergillus fumigatus.
@nl
type
label
Assessing the antifungal activ ...... ed with Aspergillus fumigatus.
@en
Assessing the antifungal activ ...... ed with Aspergillus fumigatus.
@nl
prefLabel
Assessing the antifungal activ ...... ed with Aspergillus fumigatus.
@en
Assessing the antifungal activ ...... ed with Aspergillus fumigatus.
@nl
P2093
P2860
P1476
Assessing the antifungal activ ...... ed with Aspergillus fumigatus.
@en
P2093
Karen Bartlett
Kishor M Wasan
Mike Rosland
Olena Sivak
Verica Risovic
P2860
P304
P356
10.1080/03639040601077349
P407
P577
2007-07-01T00:00:00Z